Better Utah in the News

More deaths, no benefit from drug touted by Trump to treat coronavirus, study finds

This article originally appeared on CBS News. Read it in its entirety here.

A malaria drug widely touted by President Donald Trump for treating the new coronavirus showed no benefit in a large analysis of its use in U.S. veterans hospitals. There were more deaths among those given hydroxychloroquine versus standard care, researchers reported.

The nationwide study was not a rigorous experiment. But with 368 patients, it’s the largest look so far at hydroxychloroquine with or without the antibiotic azithromycin for COVID-19, which has killed more than 171,000 people as of Tuesday.

Lauren Simpson, the policy director of Alliance for a Better Utah, voiced concerns about the purchase of the drugs.

“Aided by Senate President Adams, public funds will pay for a private gamble by Meds in Motion that could result in putting some Utahns’ health at risk,” Simpson said. “Medical professionals have expressed serious reservations with unsupervised, off-label use of anti-malarial drugs, and yet lawmakers are playing politics and bankrolling one individual’s speculative business decision at the risk of Utahns.”

This article originally appeared on CBS News. Read it in its entirety here.

Leave a Comment

Scroll to Top